Surgery, Gastroenterology and Oncology
Vol. 24, No. 2, Apr 2019
DNA Oxidation in Patients with Metastastic Colorectal Cancer: Clinical Significance of 8-Hydroxy-Deoxyguanosine as an Independent Prognostic Factor
Anatoliy Burlaka, Anastasia Vovk, Anton Burlaka, Olena Kolesnik
ORIGINAL PAPER, Apr 2019
Article DOI: 10.21614/sgo-24-2-100
Introduction: Prognosis of metastatic colorectal cancer (mCRC) patients nowadays is an important subject in the field of oncology. R0-resection of colon with primary tumor and liver metastasis remains the only treatment which significantly improves survival rate. However, recent experimental data shows that surgical trauma can indirectly stimulate tumor growth due to mitochondrial dysfunction and unregulated superoxide radical (O2-.) generation.

Aim: To study the clinical significance of 8-hydroxy-deoxyguanosine (8-OHdGu) marker, to assess the oncological effects of heat ischemia of liver parenchyma on disease prognosis in patients with mCRC. Material and methods: 69 urine 24-hour volume tests of patients with mCRC and 17 healthy individuals studied. Urine 8-OHdGu level measured using spectrophotometric method with pre-solid phase DNA extraction. The energy system and hepatocyte detoxification system state,levels of O2-. in tumor tissue determined using method of electron paramagnetic resonance (EPR) and SpinTraps technology at room temperature. Experiments carried out on a computerized EPR spectrometer RE-1307. EPR spectra recorded at temperature of liquid nitrogen (-196 C) in paramagnetically pure quartz dewar on a computerized spectrometer PE-1307 with resonator H011. Error of the method of spectrum integration and spread of spectrum reproduction of one sample is not more than 3%.

Results: The average level of marker in healthy individuals was 0.244 Â+- 0.063 nM kg · day, whereas before the resection and on day 3 after the R0-resection of liver in mCRC patients -3.42 Â+- 0.18 nM kg · day and 2,12 Â+- 0,08 nM kg · days (p <0,05), respectively. On day 3 after the liver resection due to its metastatic lesions with a total duration of heat ischemia period<30 min and> 30 min have had marker at level 2,108 Â+- 0.13 nM kg · day and 2.9883 Â+- 0.159 nM kg · day (p <0.0001), respectively. The volume of metastatic tissue significantly and directly corelated with the level of urine 8-oxodGu (R2 = 0.54, 95% CI: 0.037-0.0991, p <0.000) ,also duration of surgical intervention(â?¥300 min) and duration of worm liver ischemia(>30 min.) during the surgery significantly increased urine level of 8-oxodGu (R2 = 0.54, 95% CI: 0.001 - 0.004, p <0.001).

Conclusions: Worm liver ischemia (>30 min.), long-term surgical intervention (â?¥300 min) and metastatic tissue volume (â?¥12 cm3) in liver parenchyma in mCRC patients significantly increase urine 8-OHdGu levels. R0-resection of liver metastases in mCRC patients dicreases urine 8-OHdGu levels already on day 3 after the surgery. 8-OHdGu is a new factor of oncological prognosis in patients with mCRC.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2650


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.